Glover Stephen C. 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-12 2:58 pm Sale | 2023-04-28 | 13D | ZyVersa Therapeutics, Inc. ZVSA | Glover Stephen C. | 4,058 6.760% | -231 (-5.39%) | Filing |
| 2022-12-22 5:30 pm Purchase | 2022-12-12 | 13D | ZyVersa Therapeutics, Inc. ZVSA | Glover Stephen C. | 4,289 15.100% | 4,289 (New Position) | Filing |